You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK)獲韓國VIOL黃金微針產品中港澳獨家代理權
阿思達克 01-10 09:19
四環醫藥(00460.HK)公布,集團旗下渼顏空間近日與韓國VIOL就SYLFIRM X(黃金微針)產品達成獨家代理協議,獲得該產品在內地、香港及澳門的獨家代理權。該協議的期限為自產品獲得當地註冊許可(包括但不限於中國國家藥品監督管理局的批准)之日起十年,且產品為首次在該等地區上市。 該產品結合微針和射頻治療,利用微針將射頻照射進真皮層,用於面部皮膚組織加熱以改善皮膚皺紋及痤瘡疤痕的侵入式有創治療。其治療用途包括面部及身體的緊致和提拉、妊娠紋、痤瘡疤痕、毛細血管擴張症、黃褐斑、色素病變、血管病變、頭髮再生等多重功效,與目前上市的其他射頻微針類產品相比有較大優勢,是世界上第一台雙波作用(連續波加脈衝波)的射頻微針儀器,且已獲得美國食品藥品管理局(FDA)、韓國KFDA的認證。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account